Viatris (VTRS)
(Real Time Quote from BATS)
$10.36 USD
-0.13 (-1.24%)
Updated Jun 6, 2024 11:20 AM ET
4-Sell of 5 4
A Value C Growth C Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
VTRS 10.36 -0.13(-1.24%)
Will VTRS be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for VTRS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for VTRS
Theravance (TBPH) Q1 Earnings Top, Revenues Match Estimates
Viatris' (VTRS) Q1 Earnings & Sales Lag Estimates, Stock Down
VTRS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Viatris (VTRS) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Viatris (VTRS) Q1 Earnings and Revenues Miss Estimates
Why Earnings Season Could Be Great for Viatris (VTRS)
Other News for VTRS
Viatris to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
Viatris Appoints Rogerio Vivaldi Coelho, M.D., to Board of Directors
Viatris Inc. Expands Board and Welcomes New Expert Director
Viatris to Participate in the Jeffries Global Healthcare Conference
Viatris: Skeptics Proven Right Once Again